Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Dyslipidemias may contribute to T2DM pathogenesis; leaves open whether lipid modulation preserves beta-cell function.
LDL, HDL and cholesterol regulate the function and survival of β-cells. HDL also exerts antiobesity and insulin-sensitizing effects. Thus dyslipidemias may not only be consequences but also contributors to the pathogenesis and hence targets for prevention of T2DM.
No takes yet. Share an insight, caveat, or question.
Eckardstein et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: